Investors

People are different and so is their cancer, patients should be treated individually.

Latest News

Outcome of the IndiTreat clinical trial (TICC) is published by ASCO prior to its Annual Meeting in June 2021.

Read more

Rights Issue 2019

Memorandum

Please click here to download our Memorandum (Swedish)

Teaser

Please click here to download our Teaser

2cureX video interview, Finwire sitdown with 2cureX

Upcoming events

June 2, 2021

Redeye Growth Day 2021, Stockholm

Read more

August 28, 2021

Interim Report Q2 2021

View previous reports

November 25, 2021

Interim Report Q3 2021

View previous reports

February 24, 2022

Year-End Report 2021

View previous reports

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.

Read more